Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03181126
Title A Study of Venetoclax in Combination With Navitoclax and Chemotherapy in Subjects With Relapsed Acute Lymphoblastic Leukemia
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors AbbVie

acute lymphoblastic leukemia


Navitoclax + Venetoclax

Age Groups: child | adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope /ID# 169029 Duarte California 91010 United States Details
LPCH Stanford /ID# 163337 Palo Alto California 94304 United States Details
University of Chicago /ID# 163369 Chicago Illinois 60637 United States Details
Washington University-School of Medicine /ID# 165689 Saint Louis Missouri 63110 United States Details
Univ NC Chapel Hill /ID# 163509 Chapel Hill North Carolina 27514-4220 United States Details
Cincinnati Children's Hospital /ID# 164619 Cincinnati Ohio 45229 United States Details
Nationwide Childrens Hospital /ID# 163372 Columbus Ohio 43205 United States Details
Oregon Health and Science University /ID# 165690 Portland Oregon 97239 United States Details
St Jude Children's Research Hospital /ID# 163335 Memphis Tennessee 38105 United States Details
UT Southwestern Medical Center /ID# 163346 Dallas Texas 75390-7208 United States Details
MD Anderson Cancer Center at Texas Medical Center /ID# 163327 Houston Texas 77030-4000 United States Details
University of Wisconsin-Madiso /ID# 165691 Madison Wisconsin 53705 United States Details
Alfred Hospital /ID# 169576 Melbourne Victoria 3004 Australia Details
Victorian Comprehensive Cancer /ID# 165710 Melbourne Victoria 3050 Australia Details
Royal Children's Hospital /ID# 163322 Melbourne Victoria 3052 Australia Details
*Shaded cells indicate that there was no data available from for the field